Revised SPC: Lisoretic (hydrochlorothiazide/lisinopril dihydrate) tablets

SPC now highlights risk of choroidal effusion with visual field defect, transient myopia and acute angle-closure glaucoma. Treatment of these adverse requires rapid discontinuation of treatment, with medical/surgical management of intraocular pressure remains uncontrolled.

electronic Medicines compendium